Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial

(2011) Marcello Deraco et al.   GYNECOLOGIC ONCOLOGY

Quantitative liquid chromatographic determination of intact cisplatin in blood with microwave-assisted post-column derivatization and UV detection

(2011) Pernilla Videhult Pierre et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Pharmacokinetics and Pharmacodynamics of Perioperative Cancer Chemotherapy in Peritoneal Surface Malignancy

(2010) Kurt Van der Speeten et al.   CANCER JOURNAL

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Hyperthermic Intraperitoneal Chemotherapy Using a Closed Abdominal Procedure

(2010) Eddy Cotte et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer

(2009) Wim P. Ceelen et al.   ANNALS OF SURGICAL ONCOLOGY

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

(2008) H. Mahteme et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY